Effects of a 12 Week Milnacipran 200 mg Treatment on Pain Perception and Pain Processing in Fibromyalgia - An Open Label Study
Phase of Trial: Phase IV
Latest Information Update: 05 Nov 2016
At a glance
- Drugs Milnacipran (Primary)
- Indications Fibromyalgia
- Focus Pharmacodynamics
- 24 Oct 2016 Status changed from recruiting to completed.
- 25 Jun 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 19 Jun 2012 New trial record